Indeed, several studies have indicated that obesity is associated with enhanced SST quantity and responsiveness and that inhibition of hypothalamic SST release consistently improves GH response in obese subjects [24]. The gene discussed is GH1; the disease is obesity due to melanocortin 4 receptor deficiency.